Lung transplant: An emerging challenge in the ICU

Medicina Intensiva

Volumn 36, Issue 7, 2012, Pages 504-505

  Rello, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ACUTE RESPIRATORY FAILURE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; LUNG GRAFT REJECTION; LUNG MYCOSIS; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; SURVIVAL RATE; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS PNEUMONIA;

HUMANS; INTENSIVE CARE UNITS; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 84865984030     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2012.03.009     Document Type: Article

References (16)

1. Wolfea R.A., Merionb R.M., Roysa E.C., Porta F.K. Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant 2009, 9:869-878.
2. Harringer W., Wiebe K., Struber M., Franke U., Niedermeyer J., Fabel H., et al. Lung transplantation: 10-year experience. Eur J Cardiothorac Surg 1999, 16:546-554.
3. Boehler A., Kesten S., Wedere W., Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998, 114:1411-1426.
4. Kowalski R.J., Post D.R., Mannon R.B., Sebastian A., Wright H.I., Sigle G., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006, 82:663-668.
5. Cohen J., Singer P., Raviv Y., Bakal I., Shitrit D., Shaul Lev S., et al. Outcome of lung transplant recipients requiring readmission to the intensive care unit. J Heart Lung Transplant 2011, 30:54-58.
6. González-Castro A., Suberviola B., Llorca J., González-Mansilla C., Ortiz-Melón F., Miñambres E. Prognosis factors in lung transplant recipients readmitted to the intensive care unit. Transplant Proc 2007, 39:2420-2421.
7. Hadjiliadis H., Steele M.P., Govert J.A., Davis D., Palmer S.M. Outcome of lung transplant patients admitted to the medical ICU. Chest 2004, 125:1040-1045.
8. Pietrantoni C., Minai O.A., Yu N.C., Maurer J.R., Haug M.T., Mehta A.C., et al. Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplant. Chest 2003, 123:504-509.
9. Allan R. Antibody-mediated rejection in lung transplantation: myth or reality?. J Heart Lung Transplant 2010, 29:395-400.
10. Sacanell J. Lung transplantation. Analyses of 129 cases (Abstract). Intensive Care Med 2010, 36:S147.
11. Aguilar-Guisado M., Gavaldà J., Ussetti P., Ramos A., Morales P., Blanes M., et al. Pneumonia after lung trasnplantation in the RESITRA cohort. Am J Transplant 2007, 7:1989-1996.
12. Gavaldà J., Roman A. Infection in lung transplantation. Enferm Infecc Microbiol Clin 2007, 25:639-649.
13. Campos S., Caramori M., Teixeira R., Afonso J., Carraro R., Strabelli T., et al. Bacterial and fungal pneumonias after lung transplantation. Transplan Proceed 2008, 40:822-824.
14. Vincent J.L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., et al. International study of prevalence and outcomes of infection in ICU. JAMA 2009, 302:232318-232328.
15. Rello J., Chastre J., Cornaglia G., Masterton R. A European care bundle for management of VAP. J Crit Care 2011, 26:3-10.
16. Rello J., Ulldemolins M., Lisboa T., Koulenti D., Mañez R., Martin-Loeches I., et al. Determinants of choice and prescription in empiric antibiotic therapy for HAP/VAP. Eur Respir J 2011, 37:1332-1339.